Monday, December 13th the Board of Directors of Bristol-Myers
Squibb Company (BMY) announced
a quarterly dividend increase of from $ 0.49 to $ 0.54 per share that’s payable
February 1, 2022 to holders of record January 7, 2022. This represents a 10.20%
increase over the last quarterly dividend.
“The company’s financial position is strong, and we
remain committed to a consistent, balanced capital allocation strategy,” said
Giovanni Caforio, board chair and chief executive officer, Bristol Myers
Squibb. “With significant free cash flow of $45 billion to $50 billion expected
between 2021 and 2023, investment in business development continues to be a key
priority for the company in driving innovation and sustained growth as we
return capital to shareholders through the dividend increase and expanded share
repurchase authorization. We remain committed to maintaining a strong
investment grade credit rating and reducing our debt.”
With current price $ 62.05 (yesterday's close), this
raise brings their dividend yield to 3.48%.